510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2025-2014Class II

SmartSite Low Sorbing Infusion Set, Model Codes: 10014855A, 10015861A, 10061661A 14035457 14035485 14046894...

CareFusion 303, Inc / initiated 2014-06-17 / Terminated / root cause: labeling and UDI

CareFusion 303, Inc. began a recall of SmartSite Low Sorbing Infusion Set, Model Codes: 10014855A, 10015861A, 10061661A 14035457 14035485 14046894 14035458 on . FDA classified it as Class II and gives the reason as "CareFusion is recalling the SmartSite Low Sorbing Infusion Set because they were assembled with a drip chamber that consist of a 15 micron filter. The Directions For Use did not indicate that the drip chamber has a 15...". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-2025-2014
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
CareFusion 303, Inc
Product
SmartSite Low Sorbing Infusion Set, Model Codes: 10014855A, 10015861A, 10061661A 14035457 14035485 14046894 14035458
Product code
FPA Set, Administration, Intravascular
Reason for recall
CareFusion is recalling the SmartSite Low Sorbing Infusion Set because they were assembled with a drip chamber that consist of a 15 micron filter. The Directions For Use did not indicate that the drip chamber has a 15 micron filter and it does not provide the instruction that the set should not be used with blood administration due to the potential for occluding the 15 micron filter in the drip c
Root cause tag
labeling and UDI
FDA root cause
Labeling Change Control
Action
A recall letter is dated 6/25/14 and will be sent out to customers who purchased the SmartSite Low Sorbing Infusion Set because they were assembled with a drip chamber that consist of a 15 micron filter. The Directions For Use did not indicate that the drip chamber has a 15 micron filter and it does not provide the instruction that the set should not be used with blood administration due to the potential for occluding the 15 micron filter in the drip chamber. The letter informs the customers of the problems identified, potential risk, and actions to be taken. Customers are instructed to promptly complete and return the enclosed mandatory Customer Response Card to acknowledge the receipt of this communication and to expedite the corrective action process.
Quantity in commerce
5,600 units
Distribution
Distributed in the states of FL, NM, WA, WI, and TX.
Product codes and lots
Lot No. 14035485 14046894 14035458 14035457

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2025-2014
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2025-2014Class IITerminatedVoluntary: Firm initiated